Europe is in danger of being out-innovated in regenerative medicine – Prof. Ton Rabelink

With the right environments, stem cells can potentially be reprogrammed to grow kidney tissue.

by Frieda Klotz Regenerative medicine should be governed, firstly, by the principle of do no harm, but a better balance between risk and regulation is required to bring innovations to market more quickly, according to Ton Rabelink, professor of internal medicine and head of nephrology at Leiden University in the Netherlands. He says that Europe is in … Read more